Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
All content curated by
Published in Neurology

Journal Scan / Research · July 30, 2024

Clinical Efficacy and Safety of Intravenous Ferric Carboxymaltose Therapy for Restless Legs Syndrome

Sleep

 

Additional Info

Sleep
Clinical efficacy and safety of intravenous ferric carboxymaltose for treatment of restless legs syndrome: a multicenter, randomized, placebo-controlled clinical trial
Sleep 2024 Jul 11;47(7)1-10, CJ Earley, D García-Borreguero, M Falone, JW Winkelman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading